Clinical Trial

Comparison of Three Analgesic Strategies for Hip Fracture Surgery

Study acronym: HIP-3B
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Hip fracture surgery is associated with significant postoperative pain and increased opioid requirements. Regional anesthesia techniques may improve analgesia and reduce opioid consumption. This prospective, randomized, double-blind, controlled trial aims to compare the postoperative analgesic efficacy of Quadro-Iliac Plane Block (QIPB), Suprainguinal Fascia Iliaca Block (SIFIB), and standard analgesia in patients undergoing hip fracture surgery under spinal anesthesia. The primary outcome is cumulative tramadol consumption during the first 24 postoperative hours. Secondary outcome measures include postoperative pain intensity, rescue analgesic requirement, incidence of postoperative nausea and vomiting, Quality of Recovery-15 (QoR-15) score, and patient satisfaction score.
Trial Details
NCT Number NCT07676734
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Conditions Hip Fracture
Enrollment 90 participants
Start Date 2026-07-15
Primary Completion 2027-01 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-30